These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3018894)

  • 21. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
    Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
    Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pentamer complex-specific and IgG subclass 3 antibodies in HCMV hyperimmunoglobulin and standard intravenous IgG preparations.
    Schampera MS; Arellano-Galindo J; Kagan KO; Adler SP; Jahn G; Hamprecht K
    Med Microbiol Immunol; 2019 Feb; 208(1):69-80. PubMed ID: 30203132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selection and characterization of human monoclonal antibodies to human cytomegalovirus.
    Redmond MJ; Leyritz-Wills M; Winger L; Scraba DG
    J Virol Methods; 1986 Aug; 14(1):9-24. PubMed ID: 3021800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microneutalization of cytomegalovirus.
    Stalder H; Ehrensberger A
    J Infect Dis; 1980 Jul; 142(1):102-5. PubMed ID: 6249870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J; Peppard J; Emanuel D
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.
    Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM
    J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus polypeptides stimulate neutralizing antibody in vivo.
    Rasmussen L; Mullenax J; Nelson M; Merigan TC
    Virology; 1985 Aug; 145(1):186-90. PubMed ID: 2409670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.
    Marshall GS; Rabalais GP; Stout GG; Waldeyer SL
    J Infect Dis; 1992 Feb; 165(2):381-4. PubMed ID: 1309850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the neutralizing and ELISA antibody titres to human cytomegalovirus (HCMV) in human sera and in gamma globulin preparations.
    Schmitz H; Essuman S
    J Med Virol; 1986 Oct; 20(2):177-82. PubMed ID: 2430051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-day assay for human cytomegalovirus applicable to serum neutralization tests.
    Waner JL; Budnick JE
    Appl Microbiol; 1973 Jan; 25(1):37-9. PubMed ID: 4346976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X; Xu Y; Scott DE; Murata H; Struble EB
    Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X; Peden K; Murata H
    Vaccine; 2015 Dec; 33(51):7254-7261. PubMed ID: 26552003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid microneutralization assay for cytomegalovirus.
    Gonczol E; Furlini G; Ianacone J; Plotkin SA
    J Virol Methods; 1986 Aug; 14(1):37-41. PubMed ID: 3021795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus.
    Falk JJ; Winkelmann M; Schrezenmeier H; Stöhr D; Sinzger C; Lotfi R
    Transfusion; 2017 Feb; 57(2):412-422. PubMed ID: 27861998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant envelope protein-based enzyme immunoassay for IgG antibodies is comparable to neutralization tests for epidemiological studies of dengue infection.
    Rocha ES; Oliveira JG; Santos JR; Rodrigues GO; Figueiredo LB; Pessanha JE; Proietti FA; Fonseca FG; Bonjardim CA; Ferreira PC; Kroon EG
    J Virol Methods; 2013 Jan; 187(1):114-20. PubMed ID: 23018061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response of guinea pigs to intravaginal inoculation with guinea pig cytomegalovirus.
    Barron AL; Menna JH; Moses EB; Rank RG; Ryu H; White HJ
    Sex Transm Dis; 1989; 16(1):41-6. PubMed ID: 2547250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of cytomegalovirus IgG antibody by enzyme-linked immunosorbent assay (ELISA).
    Chia WK; Spence L
    Can J Microbiol; 1979 Sep; 25(9):1082-6. PubMed ID: 232004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.